COMMITMENT AND CONTINGENT LIABILITIES (Details Narrative) $ / shares in Units, € in Thousands |
12 Months Ended | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nov. 05, 2024
USD ($)
|
Oct. 01, 2024
EUR (€)
|
Sep. 09, 2024
USD ($)
|
Dec. 20, 2023
USD ($)
|
Jan. 26, 2023 |
Jun. 23, 2021
USD ($)
|
Jun. 01, 2021
USD ($)
|
Sep. 22, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
$ / shares
|
Dec. 31, 2023
USD ($)
$ / shares
|
Jun. 30, 2025
$ / shares
|
Feb. 12, 2025
USD ($)
|
Feb. 12, 2025
EUR (€)
|
Jan. 06, 2025
USD ($)
|
Jan. 06, 2025
EUR (€)
|
Oct. 01, 2024
$ / shares
|
Oct. 01, 2024
EUR (€)
shares
|
|
| Exercise price | $ / shares | $ 0.25 | $ 2.00 | $ 0.23 | ||||||||||||||
| Monthly fee | $ 400,000 | $ 400,000 | |||||||||||||||
| Success fees gross percentage | 6.00% | ||||||||||||||||
| Success fees percentage | 5.00% | ||||||||||||||||
| Success fees | 94,000 | 175,000 | |||||||||||||||
| Chief Executive Officer [Member] | |||||||||||||||||
| Reimbursement of expenses | $ 13,000 | $ 75,000 | $ 100,000 | ||||||||||||||
| Board of Directors Chairman [Member] | |||||||||||||||||
| Reimbursement of expenses | $ 7,000 | $ 10,000 | |||||||||||||||
| Consulting Agreement [Member] | Consultant One [Member] | |||||||||||||||||
| Maximum compensation percentage of gross profit | 25.00% | ||||||||||||||||
| Monthly fee | $ 13,000 | ||||||||||||||||
| Percentage of consultants | 5.00% | ||||||||||||||||
| Consulting Agreement [Member] | Consultant Two [Member] | |||||||||||||||||
| Monthly fee | $ 2,000 | ||||||||||||||||
| Consulting Agreement [Member] | Board of Directors Chairman [Member] | |||||||||||||||||
| Monthly fee | $ 5,000 | ||||||||||||||||
| Reimbursement of expenses | $ 1,000 | ||||||||||||||||
| Facility Agreement [Member] | |||||||||||||||||
| Credit facility | € | € 6,000 | ||||||||||||||||
| Current borrowing credit facility | € | 2,000 | ||||||||||||||||
| Remaining borrowing credit facility | € | € 4,000 | ||||||||||||||||
| Interest rate | 7.00% | ||||||||||||||||
| Credit facility drawdown amount | € | € 6,000 | ||||||||||||||||
| Drawdown period | 5 years | ||||||||||||||||
| Drawdown percentage | 33.00% | ||||||||||||||||
| Warrant term | 5 years | ||||||||||||||||
| Warrant shares | shares | 1,850,000 | ||||||||||||||||
| Exercise price | $ / shares | $ 1.00 | ||||||||||||||||
| Drawdown amount | $ 0 | $ 700,000 | € 645 | $ 405,000 | € 375 | ||||||||||||
| Israeli Innovation Authority [Member] | |||||||||||||||||
| Royalty description | Save Foods Ltd. Is committed to pay royalties to the IIA on the proceeds from sales of products resulting from research and development projects in which the IIA participates by way of grants. In the first 3 years of sales the Company will pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and thereafter the Company will pay 5% of up to 100% of the amount of grants received plus interest at SOFR for 12 months. Save Foods Ltd. was entitled to the grants only upon incurring research and development expenditures. There were no future performance obligations related to the grants received from the IIA. | ||||||||||||||||
| Royalty, contingent liabilities | $ 156,000 | $ 156,000 | |||||||||||||||
| Earthbound Technologies, LLC [Member] | Commission Agreement [Member] | Introduced Parties [Member] | |||||||||||||||||
| Percentage of net revenues | 12.50% | ||||||||||||||||
| Revenues | $ 2,000,000 | ||||||||||||||||
| Maximum compensation percentage of gross profit | 25.00% | ||||||||||||||||
| Earthbound Technologies, LLC [Member] | Commission Agreement [Member] | Introduced Parties [Member] | Exceeds in Net Revenue [Member] | |||||||||||||||||
| Revenues | $ 500,000 | ||||||||||||||||
| Options to purchase shares | shares | 1,021 | ||||||||||||||||
| Exercise price | $ / shares | $ 58.80 | ||||||||||||||||
| Earthbound Technologies, LLC [Member] | Commission Agreement [Member] | Introduced Parties [Member] | Occurance of Additional Events in Agreement [Member] | |||||||||||||||||
| Options to purchase shares | shares | 1,021 | ||||||||||||||||
| Exercise price | $ / shares | $ 58.80 | ||||||||||||||||